02607 上海醫藥
按盘价 
12.680 +0.560 (+4.620%) 非流动资产
| 2024/06 - 中期 人民币(千¥) | 与去年末期 比较 | 2023/12 人民币(千¥) | 2022/12 人民币(千¥) | 2021/12 人民币(千¥) | 2020/12 人民币(千¥) | |
| 投资物业 | 332,448 | 5.649% | 314,673 | 246,415 | 213,323 | 235,288 |
| 物业、厂房、设备及其他 | 16,176,187 | 2.871% | 15,724,684 | 14,316,653 | 13,398,248 | 12,227,920 |
| 土地及其他租赁资产 | 5,937,234 | -4.010% | 6,185,293 | 5,967,993 | 5,705,830 | 4,530,231 |
| 无形资产 | 13,295,007 | -0.837% | 13,407,187 | 13,480,734 | 13,575,007 | 13,999,942 |
| 联营公司及共同控制公司权益 | 8,153,382 | -2.377% | 8,351,910 | 9,232,644 | 9,073,275 | 6,651,064 |
| 其他非流动资产 | 5,838,645 | 5.108% | 5,554,925 | 5,377,593 | 4,975,393 | 3,978,285 |
| 49,732,901 | 0.392% | 49,538,671 | 48,622,031 | 46,941,077 | 41,622,729 | |
流动资产
| 2024/06 - 中期 人民币(千¥) | 与去年末期 比较 | 2023/12 人民币(千¥) | 2022/12 人民币(千¥) | 2021/12 人民币(千¥) | 2020/12 人民币(千¥) | ||
| 存货 | 35,255,345 | -3.735% | 36,623,394 | 34,460,217 | 27,104,035 | 24,088,258 | |
| 应收贸易帐款 | 82,655,633 | 10.439% | 74,842,530 | 68,559,438 | 59,386,651 | 53,036,445 | |
| 现金及银行结存 | 36,676,143 | 20.180% | 30,517,706 | 27,401,396 | 22,390,386 | 22,296,233 | |
| 其他流动资产 | 17,015,848 | -16.794% | 20,450,232 | 19,091,820 | 7,613,360 | 8,141,991 | |
| 持作出售资产 | 0 | -- | 0 | 0 | 0 | 0 | |
| 171,602,970 | 5.645% | 162,433,862 | 149,512,871 | 116,494,432 | 107,562,926 | ||
流动负债
| 2024/06 - 中期 人民币(千¥) | 与去年末期 比较 | 2023/12 人民币(千¥) | 2022/12 人民币(千¥) | 2021/12 人民币(千¥) | 2020/12 人民币(千¥) | |||
| 应付贸易帐款 | 58,455,897 | 6.998% | 54,632,454 | 51,565,529 | 41,995,414 | 37,792,167 | ||
| 短期借贷及租赁 | 48,792,242 | 9.462% | 44,574,707 | 37,040,364 | 32,170,096 | 34,043,154 | ||
| 其他流动负债 | 21,855,975 | -5.650% | 23,164,718 | 22,085,153 | 17,658,813 | 16,297,669 | ||
| 持作出售资产相关负债 | 0 | -- | 0 | 0 | 0 | 0 | ||
| 129,104,115 | 5.501% | 122,371,879 | 110,691,046 | 91,824,324 | 88,132,990 | |||
| 流动资产净值 | 42,498,855 | 6.083% | 40,061,983 | 38,821,825 | 24,670,109 | 19,429,937 | ||
| 资产总额减流动负债 | 92,231,757 | 2.936% | 89,600,655 | 87,443,855 | 71,611,186 | 61,052,666 | ||
非流动负债
| 2024/06 - 中期 人民币(千¥) | 与去年末期 比较 | 2023/12 人民币(千¥) | 2022/12 人民币(千¥) | 2021/12 人民币(千¥) | 2020/12 人民币(千¥) | ||||
| 长期借贷及租赁 | 8,096,672 | 10.366% | 7,336,231 | 7,561,410 | 8,592,026 | 2,685,100 | |||
| 其他非流动负债 | 1,906,463 | -1.644% | 1,938,330 | 1,879,994 | 3,952,950 | 3,626,836 | |||
| 10,003,135 | 7.856% | 9,274,562 | 9,441,404 | 12,544,975 | 6,311,936 | ||||
资本及储备
| 2024/06 - 中期 人民币(千¥) | 与去年末期 比较 | 2023/12 人民币(千¥) | 2022/12 人民币(千¥) | 2021/12 人民币(千¥) | 2020/12 人民币(千¥) | |||||
| 股本 | 3,703,523 | 0.006% | 3,703,301 | 3,697,546 | 2,842,089 | 2,842,089 | ||||
| 储备 | 66,287,161 | 2.262% | 64,820,842 | 63,365,460 | 46,517,391 | 42,512,588 | ||||
| 其他 | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 股东资金 | 69,990,684 | 2.140% | 68,524,143 | 67,063,006 | 49,359,480 | 45,354,678 | ||||
| 非控股权益 | 12,237,937 | 3.694% | 11,801,950 | 10,939,445 | 9,706,730 | 9,386,052 | ||||
| 其他 | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 82,228,621 | 2.369% | 80,326,093 | 78,002,451 | 59,066,210 | 54,740,730 | |||||
承担及或然负债
| 2024/06 - 中期 人民币(千¥) | 与去年末期 比较 | 2023/12 人民币(千¥) | 2022/12 人民币(千¥) | 2021/12 人民币(千¥) | 2020/12 人民币(千¥) | |
| 承担 | -- | -- | 1,466,817 | 1,502,491 | 355,216 | 659,867 |
| 或然负债 | -- | -- | 0 | 0 | 0 | 0 |
| 备注： | 实时报价更新时间为30/09/2024 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB 2,941,911 |
| 增长率 | 12.725% |
| 每股盈利/(亏损) | RMB 0.790 |
| 每股账面资产净值 (¥) | RMB 18.898 |